The leaders of the biggest A.I. labs argue that artificial intelligence will usher in a new era of scientific discovery, which will help us cure diseases and accelerate our ability to address the climate crisis. But what has A.I. actually done for science so far?

To understand, we asked Sam Rodriques, a scientist turned technologist who is developing A.I. tools for scientific research through his nonprofit FutureHouse and a for-profit spinoff, Edison Scientific. Edison recently released Kosmos — an A.I. agent, or A.I. scientist to use the company’s language, that it says can accomplish six months of doctoral or postdoctoral-level research in a single 12-hour run.

Sam walks us through how Kosmos works, and why tools like it could dramatically speed up data analysis. But he also discusses why some of the most audacious claims about A.I. curing disease are unrealistic, as well as what bottlenecks still stand in the way of a true A.I.-accelerated future.

Guest:

Sam Rodriques, founder and chief executive of FutureHouse and Edison Scientific

Additional Reading:

We want to hear from you. Email us at hardfork@nytimes.com. Find “Hard Fork” on YouTube and TikTok.

Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app.

Interest only mortgages, structured products and foreign property dreams gone sour